Fortis Malar Hospitals has ceased all operations after a slump sale. For FY26, it reported a profit of ₹4.2 crore from non-operational income. Investors should watch restructuring plans and legal disputes.
Fortis Malar Hospitals Ceases Operations, Reports Profit from Non-Operational Income
Fortis Malar Hospitals Ltd. reported a profit of ₹4.20 crore for FY 2026, primarily from non-operational income, as the company has ceased all business operations post slump sale.
Reader Takeaway: No growth outlook; focus on restructuring and legal case resolution.
What just happened
Fortis Malar Hospitals has ceased all its business operations following a slump sale of its business to MGM Healthcare Private Limited on February 1, 2024. As of March 31, 2026, the company has no permanent employees and no visibility of commencing new operations.
Why this matters
The company is now functioning as a shell or holding entity. The reported income of ₹6.30 crore and profit of ₹4.20 crore for FY26 are non-operational, derived from existing cash or investments. This means the company's financial performance is not tied to active healthcare services.
The backstory
The company's core business was divested through a slump sale. An open offer by IHH Healthcare Berhad/NTK was completed on November 10, 2025, with the price adjusted to ₹17.60 per share.
What changes now
Management is currently evaluating corporate restructuring options. The company continues to maintain its going concern status, supported by its cash holdings.
Risks to watch
The company faces ongoing legal and tax disputes, including VAT, GST, and income tax appeals. These represent contingent liabilities that could impact the company's cash reserves.
Peer comparison
N/A, as the company has divested its operational business and is no longer comparable to active healthcare providers.
Context metrics (time-bound)
- Total Income (FY 2026): ₹6.30 crore (Standalone)
- Profit for the year (FY 2026): ₹4.20 crore (Standalone)
- Slump Sale Date: February 1, 2024
- Open Offer Completion: November 10, 2025
What to track next
Investors should monitor the progress of corporate restructuring plans and the outcomes of ongoing tax and legal disputes. The utilization of remaining cash balances will also be a key factor.